Agilon health, inc. AGL.US Overview
AGL AI Analysis & Strategy
Browsing restrictions can be lifted for a fee.
AGL Current Performance
0.46%
Agilon health, inc.
1.60%
Avg of Sector
0.54%
S&P500
AGL Key Information
AGL Revenue by Segments
Browsing restrictions can be lifted for a fee.
AGL Net Income
Browsing restrictions can be lifted for a fee.
AGL Cash Flow
Browsing restrictions can be lifted for a fee.
AGL Profit Margin
Browsing restrictions can be lifted for a fee.
AGL PE Ratio River
Browsing restrictions can be lifted for a fee.
AGL Financial Forecast
Browsing restrictions can be lifted for a fee.
AGL Earnings Table
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | |||||||
| 2024Q4 | |||||||
| 2024Q3 | |||||||
| 2024Q2 | |||||||
| 2024Q1 |
AGL Profile
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
Price of AGL
AGL FAQ
When is AGL's latest earnings report released?
The most recent financial report for Agilon health, inc. (AGL) covers the period of 2025Q1 and was published on 2025/03/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating AGL's short-term business performance and financial health. For the latest updates on AGL's earnings releases, visit this page regularly.
What is the operating profit of AGL?
According to the latest financial report, Agilon health, inc. (AGL) reported an Operating Profit of -22.11M with an Operating Margin of -1.44% this period, representing a decline of 208.02% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
How is AGL's revenue growth?
In the latest financial report, Agilon health, inc. (AGL) announced revenue of 1.53B, with a Year-Over-Year growth rate of -4.46%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
How much cash does AGL have?
At the end of the period, Agilon health, inc. (AGL) held Total Cash and Cash Equivalents of 138.62M, accounting for 0.07 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
Does AGL go with three margins increasing?
In the latest report, Agilon health, inc. (AGL) did not achieve the “three margins increasing” benchmark, with a gross margin of 3.3%%, operating margin of -1.44%%, and net margin of 0.8%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess AGL's profit trajectory and future growth potential.
Is AGL's EPS continuing to grow?
According to the past four quarterly reports, Agilon health, inc. (AGL)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.03. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
What is the FCF of AGL?
Agilon health, inc. (AGL)'s Free Cash Flow (FCF) for the period is -35.84M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 29.62% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.
What are the PEG ratio and PE ratio of AGL?
The latest valuation data shows Agilon health, inc. (AGL) has a Price-To-Earnings (PE) ratio of -7.63 and a Price/Earnings-To-Growth (PEG) ratio of -0.33. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.